Nasdaq-Listed Enlivex Plans $212M RAIN Token Play with Ex-Italian PM Onboard

Why It Matters

The move signals a rare, high‑profile corporate entry into crypto prediction markets, potentially validating the sector and influencing other firms’ treasury strategies, while Renzi’s board role adds political and regulatory credibility to the venture.

Summary

Nasdaq‑listed biotech Enlivex Therapeutics announced a $212 million private investment in public equity offering, selling 212 million shares at $1 each—a roughly 11.5% discount to the prior close. The proceeds will be used to purchase the Rain (RAIN) utility token, the native token of a decentralized prediction‑market platform on Arbitrum, making Enlivex the first public company to center its strategy on a prediction‑market token. Former Italian prime minister Matteo Renzi will join Enlivex’s board to guide its treasury and regulatory strategy as the firm pivots from immunotherapy to crypto assets. Rain, the 203rd‑largest token by market cap, has a $862 million valuation and has surged roughly 795% since launch, while Enlivex’s stock has fallen more than 20% YTD.